BIONOMICS LTD-ADR (BNOX) Stock Analyst Ratings
NASDAQ:BNOX - Nasdaq - US09063M2052 - ADR
ChartMill assigns a Buy % Consensus number of 83% to BNOX. The Buy consensus is the weighted average rating of the current analysts ratings.
BNOX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about BNOX.
In the previous month the buy percentage consensus was at a similar level.
BNOX was analyzed by 8 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-08-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-06-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-21 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-12-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-09-28 | Maxim Group | Maintains | Buy -> Buy |
| 2023-09-28 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |
| 2023-06-16 | Maxim Group | Initiate | Buy |
| 2023-03-10 | Evercore ISI Group | Upgrade | In-Line -> Outperform |
| 2023-03-09 | Loop Capital | Maintains | Buy |
| 2023-03-09 | HC Wainwright & Co. | Maintains | Neutral |
| 2022-12-20 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-12-19 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-11-01 | Loop Capital | Initiate | Buy |
| 2022-01-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2022-01-10 | Berenberg | Initiate | Buy |
| 2022-01-10 | Evercore ISI Group | Initiate | Outperform |